CFDE Workbench
DataKnowledgeCloudtrainingcoordination
CFDE Workbench

COL Q15165-2 GLY 000888 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)
Protein:

PON2 HUMAN

Protein (Entity type)
Project:

Portal

Project (Entity type)
Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)
Dcc:

GlyGen

DCC (Entity type)
Collection:

human proteoform glycosylation sites embl.csv

File (Entity type)
Description:Information for protein Q15165-2 in the context of file GLY_000888
Creation Time:2026-03-02 19:57:27.000000
Results found

Linked to

 

Label

Description

 

Compound

G88520YF

Compound (Entity type)

type="BaseComposition" mass="990.294111335" permass="1242.57581259" monosaccharides="5" is_motif="Fa...

Protein

PON2 HUMAN

Protein (Entity type)

Serum paraoxonase/arylesterase 2

Post Translational Modification

q15165-2 254asn 254asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q15165-2 323asn 323asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q15165-2 269asn 269asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q15165-2 226asn 226asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Compound

G03930VE

Compound (Entity type)

type="Composition" mass="4297.49245284" permass="5348.66620809" monosaccharides="21" is_motif="False...

  • Compound

    G88520YF

    Compound (Entity type)

    type="BaseComposition" mass="990.294111335" permass="1242.57581259" monosaccharides="5" is_motif="Fa...

  • Protein

    PON2 HUMAN

    Protein (Entity type)

    Serum paraoxonase/arylesterase 2

  • Post Translational Modification

    q15165-2 254asn 254asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    q15165-2 323asn 323asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    q15165-2 269asn 269asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    q15165-2 226asn 226asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Compound

    G03930VE

    Compound (Entity type)

    type="Composition" mass="4297.49245284" permass="5348.66620809" monosaccharides="21" is_motif="False...

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2026
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2026
    This repository is under review for potential modification in compliance with Administration directives.